Nektar Therapeutics (NKTR)

NASDAQ: NKTR · Real-Time Price · USD

41.17

+0.37 (0.91%)

At close: Oct 9, 2026, 4:00 PM EDT

41.72

+0.55 (1.34%)

Pre-market: Oct 12, 2026, 4:01 AM EDT

Nektar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,406	860	172	108	425	2,493
Market Cap Growth	30.67%	401.35%	59.16%	-74.63%	-82.96%	-18.24%
Enterprise Value	857	757	129	-20	179	1,866
Last Close Price	41.17	42.28	13.95	8.47	33.90	202.65

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	15.88	15.88	15.88	15.88	15.88
PS Ratio	25.75	15.57	1.74	1.20	4.61	24.47
PB Ratio	1.56	9.57	2.82	0.82	1.16	3.67
P/TBV Ratio	1.56	9.57	2.82	0.82	1.46	4.14

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	15.70	13.70	1.31	-	1.94	18.31

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.15	1.66	3.20	1.76	0.78	0.50
Net Debt / Equity Ratio	-0.61	-1.08	-1.23	-0.76	-0.59	-0.68
Net Debt / EBITDA Ratio	4.22	0.75	0.60	0.78	0.96	1.07
Net Debt / FCF Ratio	2.34	0.46	0.42	0.51	0.70	1.08
Asset Turnover	0.08	0.19	0.28	0.16	0.10	0.08
Inventory Turnover	-	-	-	1.91	1.24	1.60
Quick Ratio	9.71	4.62	4.18	5.97	7.53	8.90
Current Ratio	10.42	4.97	4.26	6.45	8.01	9.34
Return on Equity (ROE)	-35.75%	-217.94%	-124.10%	-110.95%	-70.39%	-59.64%
Return on Assets (ROA)	-12.54%	-27.98%	-23.14%	-15.25%	-16.43%	-21.00%
Return on Invested Capital (ROIC)	-51.66%	-	-450.92%	-131.09%	-111.04%	-137.22%
Return on Capital Employed (ROCE)	-12.80%	-57.60%	-53.60%	-39.00%	-37.40%	-43.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-11.18%	-19.08%	-69.35%	-256.12%	-86.68%	-21.01%
FCF Yield	-16.70%	-24.34%	-103.28%	-179.50%	-72.91%	-17.15%
Buyback Yield / Dilution	-73.25%	-23.05%	-8.24%	-1.53%	-2.10%	-2.64%

SEC Filings: 10-K · 10-Q